Bill Nygren - Harris Associates L P
Holding/activity history for Boston Scientific (BSX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2013 Q1 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2012 Q4 | 255,935 | <0.01 | Reduce 98.98% | 0.37 | $5.73 | $1,467,000 | SEC |
| 2012 Q3 | 25,068,789 | 0.37 | Reduce 29.71% | 0.16 | $5.74 | $143,895,000 | SEC |
| 2012 Q2 | 35,665,535 | 0.54 | Reduce 19.48% | 0.14 | $5.67 | $202,224,000 | SEC |
| 2012 Q1 | 44,296,035 | 0.74 | Reduce 4.84% | 0.04 | $5.98 | $264,890,000 | SEC |
| 2011 Q4 | 46,550,535 | 0.83 | Reduce 24.88% | 0.33 | $5.34 | $248,580,000 | SEC |
| 2011 Q3 | 61,972,135 | 1.34 | Add 7.28% | 0.09 | $5.91 | $366,255,000 | SEC |
| 2011 Q2 | 57,767,135 | 1.32 | Add 13.47% | 0.16 | $6.91 | $399,171,000 | SEC |
| 2011 Q1 | 50,908,735 | 1.23 | Add 28.29% | 0.27 | $7.19 | $366,034,000 | SEC |
| 2010 Q4 | 39,682,135 | 0.96 | Add 75.07% | 0.41 | $7.57 | $300,393,000 | SEC |
| 2010 Q3 | 22,667,035 | 0.69 | Add 297.36% | 0.52 | $6.13 | $138,949,000 | SEC |
| 2010 Q2 | 5,704,402 | 0.15 | Buy | 0.15 | $5.80 | $33,086,000 | SEC |